5.11
-0.05(-0.97%)
Currency In USD
| Previous Close | 5.16 |
| Open | 5.12 |
| Day High | 5.26 |
| Day Low | 5 |
| 52-Week High | 11.55 |
| 52-Week Low | 2.35 |
| Volume | 802,692 |
| Average Volume | 519,722 |
| Market Cap | 342.68M |
| PE | -2.3 |
| EPS | -2.22 |
| Moving Average 50 Days | 6.46 |
| Moving Average 200 Days | 5.57 |
| Change | -0.05 |
Data not available
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
GlobeNewswire Inc.
Oct 02, 2024 1:00 PM GMT
Name change to "Climb Bio" marks the Company’s transition and focus on developing treatments for immune-mediated diseases Climb Bio will begin trading on Nasdaq under the trading symbol "CLYM" effective October 3rd WELLESLEY, Mass., Oct. 02, 2024 (
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
GlobeNewswire Inc.
Sep 11, 2024 11:00 AM GMT
SEATTLE and CAMBRIDGE, United Kingdom, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced today members of the management team will participate at the Stifel 2024 Virtual Immunology and Inflammation Summit being h